Plasma Interleukin-37 is Elevated in Acute Ischemic Stroke Patients and Probably Associated With 3-month Functional Prognosis 

BACKGROUND: Interleukin-37 is a novel cytokine emerging as a natural suppressor of inflammatory responses. Inflammation and the immune response play important roles in acute ischemic stroke. This study aimed at evaluating the plasma levels and the association with 3-month outcomes of interleukin-37...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Feng, Zhu, Tianrui, Li, Heng, He, Yi, Zhang, Yuanyuan, Huang, Nana, Zhang, Guitao, Li, Yanshuang, Chang, Dujuan, Li, Xiaohong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414924/
https://www.ncbi.nlm.nih.gov/pubmed/32801675
http://dx.doi.org/10.2147/CIA.S230186

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414924/
https://www.ncbi.nlm.nih.gov/pubmed/32801675
http://dx.doi.org/10.2147/CIA.S230186

Ejemplares similares